Evidence map›Paper›PMID 33408612›Full record

ArticleFrontiers in cellular neuroscience2020

Targeting MicroRNA-125b Promotes Neurite Outgrowth but Represses Cell Apoptosis and Inflammation via Blocking PTGS2 and CDK5 in a FOXQ1-Dependent Way in Alzheimer Disease.

Jingcong Zhuang, Zhongjie Chen, Pingping Cai, Rong Wang, Qingwei Yang, Longling Li, Huili Yang, Renjing Zhu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Protective effect of baicalein fromFrontiers in aging neuroscience · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Foxq1 activates CB2R with oleamide to alleviate POCD.Brain pathology (Zurich, Switzerland) · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Molecular Mechanisms of Medicinal PlantCurrent pharmaceutical design · 2024
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jingcong ZhuangDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Zhongjie ChenDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Pingping CaiDepartment of Neurology, Fujian Medical University Xiamen Humanity Hospital, Xiamen, China.
Rong WangDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Qingwei YangDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Longling LiDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Huili YangDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Renjing ZhuDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Zhongshan Hospital of Xiamen University · CNFujian Medical University · CNXiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to explore the molecular regulatory network among microRNA-125b (miR-125b), forkhead box Q1 (FOXQ1), prostaglandin-endoperoxide synthase 2 (PTGS2), and cyclin-dependent kinase 5 (CDK5), as well as their effects on cell apoptosis, neurite outgrowth, and inflammation in Alzheimer disease (AD). Rat embryo cerebral cortex neurons and nerve growth factor-stimulated PC12 cells were insulted by Aβ

Indexed as

Alzheimer's diseaseCDK5FOXQ1MicroRNA-125bPTGS2

Identifiers

PMID33408612
PMCPMC7779636
OpenAlexW3115119704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.